Login

Evli Fund Management Company Ltd. provides insights into the market outlook for infrastructure investments. 00:10:00

Share On Facebook Share On Twitter

Mikael Thunved is CEO:Evli AB at Evli Fund Management Co Ltd

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
A video showcasing the manufacturing process of glass bottles by BG Container Glass PCL |Silparat Watthanakasetr is currently the Chief Executive Officer & Executive Director at BG Container Glass PCL.
00:10:00
Peter Kaufman on Navigating Capital Structure Stress in 2024
00:10:00
Exploring the World of Children's Content with Genius Brands International CEO Andy Hayward
00:10:00
Strategic Growth and Innovations Propel Cannabis Industry Success | Miguel Martin, CEO, Aurora Cannabis Inc.
00:10:00
Stephen Feinberg Aims to Retain Cerberus Stake Amid Trump Administration Advisory Role
00:10:00
The Right Time to Invest Outside of Silicon Valley|Saurabh Gupta,Cofounder And Managing Partner, DST Global
00:10:00
Navigating Digital Investments: Deryck Graham on the Radiance Multi-Strategy Fund | Deryck Graham - CEO & Founder, Portal Asset Management
00:10:00
The State of The Fundraising & Startup Market|Tomasz Tunguz,Managing Director,Redpoint
00:10:00
Versatile Power: From Grid-Saving Container-Sized Batteries to Portable Camping Solutions|CFO, Billion Electric Co Ltd
00:10:00
Key Fund Management Insights from Michael Reeves
00:10:00
Daniel Rabie is Chief Executive Officer at GetBusy Plc.
00:10:00
CEO Chip Paucek on the Company’s 257% Surge and Strategic University Partnerships | Chip Paucek, CEO , 2U Inc.

© 2026 Nehu